Archive · 1 Oct 2026
CBI Files Cases Over Alleged CGHS Medicine Procurement Bribery
The CBI is investigating suspected bribery in the purchase of medicines.
The medicines were bought for the Central Government Health Scheme.
Some government employees allegedly worked with private pharmaceutical companies.
They allegedly helped place orders and approve payments.
Investigators say some medicines were bought at the highest allowed prices.
They also say bills were cleared without checking the deliveries properly.
Money transfers between officials and private staff raised further concerns.
The investigation may identify more people involved.
The CBI registered cases against pharmaceutical firms, representatives and CGHS employees.
Officials allegedly accepted bribes and procured medicines at maximum government-fixed rates.
The accused allegedly issued supply quotations and cleared bills without physical verification.
Investigators identified suspicious money transfers between public servants and pharmaceutical staff.
The inquiry is continuing to determine the full scope of the alleged network.
- Who
- The Central Bureau of Investigation, pharmaceutical firms and representatives, and current and former Central Government Health Scheme employees.
- What
- The CBI registered criminal cases over alleged bribery, inflated medicine procurement and irregular bill clearances.
- Where
- The case involves CGHS operations in Hyderabad, Bengaluru, Kothapet and Secunderabad.
- Why
- Officials allegedly accepted bribes, issued supply quotations, procured medicines at maximum government-fixed rates and cleared bills without required physical verification.
- Investigating agency
- Central Bureau of Investigation
- Scheme involved
- Central Government Health Scheme
- Companies named
- Lorven Pharma and Surgicals; New SS Medical and General Stores
- Medicines mentioned
- Antioxidants, Sacubitril 24 mg with Valsartan 26 mg, Sitagliptin 50 mg, and Metformin 500 mg
- Alleged conduct
- Bribe-taking, inflated-rate procurement, supply quotations and bill clearances without physical verification
- Financial evidence
- Suspicious transfers between public servants and private pharmaceutical staff
- Investigation status
- The coordinated investigation remains underway